SARS-CoV-2 spike
[용어속성] Term
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
혈청학 분석을 위한 SARS-CoV-2 스파이크 수용체 결합 도메인(RBD) 생산 개선
Article
[키워드] Antigen
assays
can be used
Cell culture
COVID-19
Critical
demonstrated
DNA
domain
element
ELISA
expression
form
functional
IMPROVE
Improved
investigated
parameters
peptides
promoter
Protein
protein expression
protein production
purification
RBD
reagent
Receptor-binding domain
responsible
robust
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike
sensitivity
serology
serology assay
serology assays
Spike protein
Support
the RBD protein
the SARS-CoV-2
variable
[DOI] 10.1016/j.pep.2020.105802 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.pep.2020.105802 PMC 바로가기 [Article Type] Article
SARS-CoV-2 spike D614G change enhances replication and transmission
Research
[키워드] ACE2
airway
angiotensin-converting enzyme 2
binding
circulating
COVID-19
Culture
D614G
D614G substitution
ENhance
epithelial
Evolution of SARS-CoV-2
founder effect
Human
human ACE2
humans
IMPROVE
in vitro
increases in
nasal
predominant
Prevalence
provide
receptor
reflect
Replication
SARS-COV-2 infection
SARS-CoV-2 spike
SARS-CoV-2 variant
spike glycoprotein
the SARS-CoV-2
Transmissibility
Transmission
variant
virus
[DOI] 10.1038/s41586-021-03361-1 [Article Type] Research
[DOI] 10.1038/s41586-021-03361-1 [Article Type] Research
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy
Article
[키워드] affected
age
antibodies
antibody
Antibody Response
Asymptomatic
Brescia
carried
conducted
COVID-19
COVID-19 pandemic
cumulative
detectable
develop
effort
epidemiological data
Europe
HCW
HCWs
health care workers
health-care
IgG level
Italy
lombardy
neutralizing effect
pandemic
positive RT-PCR
Prevalence
response
retrospective
SARS CoV-2
SARS-CoV-2
SARS-CoV-2 IgG
SARS-COV-2 infection
SARS-CoV-2 spike
seropositive
seropositive participant
Seroprevalence
serum sample
severity
study period
Swab
Symptom
Tertiary
tested
was used
with COVID-19
worker
[DOI] 10.3390/microorganisms9030488 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/microorganisms9030488 PMC 바로가기 [Article Type] Article
Flexibility and mobility of SARS-CoV-2-related protein structures
SARS-CoV-2 관련 단백질 구조의 유연성 및 이동성
Article
[키워드] antiviral drug
Biochemistry
Biological physics
Biophysics
Complete
Computational biology and bioinformatics
database
develop
Docking studies
docking study
domain
drugs
example
flexibility
identify
in silico
in vitro
in vivo
information
movement
pandemic
PDB
Protein
protein structures
Proteins
resolved
rigidity
S1 subunit
SARS-CoV-2 drug
SARS-CoV-2 spike
SARS-CoV-2 spike protein
Scientific community
Structure
structures
targets
the S1 subunit
the SARS-CoV-2
Vaccine
Viral proteins
[DOI] 10.1038/s41598-021-82849-2 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-82849-2 PMC 바로가기 [Article Type] Article
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
Iota-carrageenan은 SARS-CoV-2를 중화하고 시험관 내에서 바이러스 복제를 억제합니다
Research Article
[키워드] absence
acute respiratory syndrome
administration
attachment
caused
cell entry
clinical effectiveness
common cold
competent
coronavirus
demonstrated
dose
duration of symptom
effective
Endemic
in vitro
in vitro data
inhibit
iota-carrageenan
lentivirus
nasal
Nasal spray
neutralize
neutralized
Particle
Patient
Prophylactic
Prophylaxis
pseudotyped
public health threat
reduction
Replication
respiratory
respiratory viruses
Safe
SARS-CoV-2
SARS-CoV-2 infections
SARS-CoV-2 spike
SARS-CoV-2 spike pseudotyped lentivirus
SARS-CoV-2 virus
Severe acute respiratory syndrome
Severe acute respiratory syndrome-related coronavirus
severity
spike glycoprotein
the cell
the SARS-CoV-2
therapeutic
translated
Treatment
Vaccine
viral replication
wild type
[DOI] 10.1371/journal.pone.0237480 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0237480 PMC 바로가기 [Article Type] Research Article
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
구조 유도 다가 나노바디는 SARS-CoV-2 감염을 차단하고 돌연변이 탈출을 억제합니다
Research Article
[키워드] absence
activate
Activation
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
addition
Administered
alpaca
antibodies
antibody
Attention
battle
binding
binding mode
binding modes
Bivalent
catalyzed
caused
Cell
cellular membrane
cellular membranes
change
Combination
combinations
complex
conformation
conformational change
Consequences
coronavirus
COVID-19
cryo-EM
Crystallography
determined by
domain
effective
epitope
Epitopes
escape mutant
escape mutants
Evolution
experiment
experiments
expression
fusion
Health care
health care systems
High-risk patients
immune system
immunization
immunized
inactivated
inactivated virion
inactive
independent
induce
Infection
information
inhalation
inhibit
inhibited
Interaction
interactions
lead
llama
mechanism
Microscopy
monoclonal antibodies
multivalent
mutants
nanobodies
nanobody
neutralization
neutralize
neutralized
Neutralizing
Neutralizing activity
observation
offer
pandemic
passive immunization
Perspective
postfusion
Premature
Prevent
prevented
Protein
RBD
RBDs
receptor
receptor ACE2
Receptor binding
Receptor binding domain
respiratory
resulting
reveal
Safe
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike
SARS-CoV-2 spike protein
SARS-CoV-2 spike trimer
Science
severe acute respiratory syndrome Coronavirus
Simultaneous
Society
Spike protein
spike trimers
Spread
stomatitis
strength
Structure
structures
suppress
suppressed
target membrane
target membranes
the RBD
the SARS-CoV-2
the spike protein
to define
Trigger
triggered
triggering
triggers
trimeric spike
trivalent
Vaccines
variable
vesicular stomatitis
vesicular stomatitis virus
Viral
viral escape
viral infection
viral infections
viral spike protein
virion
virions
virus
X-ray crystallography
[DOI] 10.1126/science.abe6230 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1126/science.abe6230 PMC 바로가기 [Article Type] Research Article
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors
중증 COVID-19 회복기 기증자로부터 분리된 항체에 의한 다중 클론 SARS-CoV-2 중화
Research Article
[키워드] analyzed
anti-SARS-CoV-2
antibodies
antibody
Antibody Response
Antibody responses
antigenic
antigenic stimulation
approaches
Author
B cell
B cell response
B cell responses
BCR
binding site
cloned
Combination
combinations
contribute
convalescent
correlated
COVID-19
Culture
demonstrated
Donor
donors
effective
ELISA
epitope
Epitopes
exhibited
feature
fusion
germline
healthy
Immune cell
immune cells
infected cells
Infection
inhibited
Interaction
Live virus
mAb
mAbs
majority
mapped
Mild
molecular
monoclonal antibody
Mutagenesis
NAb
NAbs
neutralization
Neutralizing
Neutralizing antibodies
neutralizing antibody
neutralizing response
Pathogenesis
pathogenesis of COVID-19
Patient
peptide
performed
plasma IgG
post infection
precursor
precursors
Prevent
produced
protective immunity
RBD
receptor
Receptor binding domain
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 neutralization
SARS-CoV-2 spike
Sequencing
Severe case
severe cases
severe COVID-19
severe disease manifestations
Severe infection
spike
Spike receptor binding domain
Support
syncytia formation
the RBD
the SARS-CoV-2
the Spike
therapy
titers of IgG
treat
two group
two groups
uninfected
unique
VH3-53
[DOI] 10.1371/journal.ppat.1009165 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.ppat.1009165 PMC 바로가기 [Article Type] Research Article
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2
Cellular Response to Infection
[키워드] Activation
Antiviral
antiviral activity
cathepsin
Cell
cellular entry
cleavage
cleavage site
consequence
coronavirus
COVID-19
entry of SARS-CoV-2
exacerbated
expression
furin cleavage
furin cleavage site
furin-like protease
glycoprotein
IFITM
IFITM2
IFITM3
individuals
inhibit
inhibited
innate immune
Innate immunity
interferons (IFNs
late endosomes
maturation
membrane protein
mitigate
polybasic
potential therapeutic target
precursor
producer cell
promote
protease
Protein
reduce
reduce viral replication
Replication
restrict
S1/S2 boundary
SARS-CoV-1
SARS-CoV-1 and -2
SARS-CoV-2
SARS-CoV-2 entry
SARS-CoV-2 replication
SARS-CoV-2 spike
sensitivity
Site
spike
suggested
the spike protein
therapeutic strategy
transmembrane
Transmissibility
transmissibility of SARS-CoV-2
Transmission
Treatment
Type
type 1 interferon
type I
type I IFNs
type I interferon
type II IFN
viral entry
viral spike
viruses
[DOI] 10.1128/JVI.02422-20 PMC 바로가기 [Article Type] Cellular Response to Infection
[DOI] 10.1128/JVI.02422-20 PMC 바로가기 [Article Type] Cellular Response to Infection